Authors: FROON AMF GREVE JWM BUURMAN WA VANDERLINDEN CJ LANGEMEIJER HJM ULRICH C BOURGEOIS M

Citation: Amf. Froon et al., TREATMENT WITH THE PLATELET-ACTIVATING-FACTOR ANTAGONIST TCV-309 IN PATIENTS WITH SEVERE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME - A PROSPECTIVE, MULTICENTER, DOUBLE-BLIND, RANDOMIZED PHASE-II TRIAL, Shock, 5(5), 1996, pp. 313-319